Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | ABL1 | P00519 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 5/20 | 0.42 |
| ▸ | RAB9A | P51151 | 5/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | WNT1 | P04628 | 1/20 | 0.40 |
| ▸ | GSK3B | P49841 | 1/20 | 0.40 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31455455 | 0.99 | KMT2A (0.45) | KMT2AMEN1ABL1NPC1RAB9A | |
| SCHEMBL31455390 | 0.83 | HDAC2 (0.56) | ABL1NPC1RAB9AWNT1GSK3B | |
| SCHEMBL31455231 | 0.72 | KDR (0.46) | KMT2AMEN1ABL1NPC1RAB9A | |
| SCHEMBL31455084 | 0.69 | MAPT (0.39) | KMT2AMEN1ABL1NPC1RAB9A | |
| SCHEMBL31455494 | 0.69 | HDAC1 (0.44) | KMT2AABL1NPC1RAB9AMAPT | |
| SCHEMBL31455333 | 0.69 | MAPT (0.38) | KMT2AMEN1ABL1NPC1RAB9A | |
| SCHEMBL374880 | 0.68 | ABL1 (0.54) | KMT2AABL1NPC1RAB9AALDH1A1 | |
| SCHEMBL374881 | 0.68 | ABL1 (0.54) | KMT2AABL1NPC1RAB9AALDH1A1 | |
| SCHEMBL13702043 | 0.68 | NPC1 (0.63) | KMT2AMEN1NPC1RAB9AALDH1A1 | |
| SCHEMBL3056248 | 0.67 | NPC1 (0.55) | KMT2AMEN1ABL1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025059577-A1 | SUBSTITUTED AMINOPYRIDINE COMPOUNDS FOR USE AS AKT1 INHIBITORS | ATAVISTIK BIO, INC. (US) | 2025-03-20 | — | — | WO | disclosed |